secwatch.observer — SEC 8-K summary
======================================

Issuer:     GERON CORP (GERN)
CIK:        0000886744
Form:       8-K
Filed at:   2022-09-08T23:59:59+00:00
Accession:  0000950170-22-018252
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Geron appoints John F. McDonald to Board of Directors
-----------------------------------------------------

- John F. McDonald appointed as Class I director, term expiring at 2024 annual meeting.
- McDonald is Corporate VP, Global R&D Business Development at Novo Nordisk; previously VP at Biogen.
- Received initial option grant for 200,000 shares at $2.72/share, vesting over 3 years.
- Eligible for annual option grants of 125,000 shares and $42,500 cash retainer.
- Board determined McDonald is independent under Nasdaq and SEC rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886744/000095017022018252/0000950170-22-018252-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886744/000095017022018252/gern-20220907.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-018252

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer